Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology.

MLA

Ramanan, Vijay K., et al. “Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology.” Neurology, vol. 101, no. 19, Nov. 2023, pp. 842–52. EBSCOhost, https://doi.org/10.1212/WNL.0000000000207757.

APA

Ramanan, V. K., Armstrong, M. J., Choudhury, P., Coerver, K. A., Hamilton, R. H., Klein, B. C., Wolk, D. A., Wessels, S. R., & Jones Jr., L. K. (2023). Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology. Neurology, 101(19), 842–852. https://doi.org/10.1212/WNL.0000000000207757

Chicago

Ramanan, Vijay K., Melissa J. Armstrong, Parichita Choudhury, Katherine A. Coerver, Roy H. Hamilton, Brad C. Klein, David A. Wolk, Scott R. Wessels, and Lyell K. Jones Jr. 2023. “Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology.” Neurology 101 (19): 842–52. doi:10.1212/WNL.0000000000207757.